EGRESS

Welcome to the Brand page for “EGRESS”, which is offered here for Vaccines; oral vaccines; modified cells for medical or clinical use; pharmaceuticals in the nature of yeast-based pharmaceuticals; oral vaccine preparations; pharmaceutical products for the treatment of infectious diseases; recombinant yeast-based pharmaceutical products; yeast-based oral vaccines; pharmaceutical preparations, a drug delivery system comprising yeast-based oral vaccines; pharmaceutical products, yeast-based oral vaccines; biological and pharmaceutical preparations, recombinant yeast for medical use;.

Its status is currently believed to be active. Its class is unavailable. “EGRESS” is believed to be currently owned by “Esperovax, Inc.”